GENE ONLINE|News &
Opinion
Blog

Trials & Approvals
Empliciti®(elotuzumab) combination – New IO approval for relapsed Multiple Myeloma
2018-11-09
Next Gen IO update – early phase clinical trials of anti-TIGIT/LAG3 antibodies
2018-11-08
Pembrolizumab Upstages Topline PD-1/L1 drugs in lung cancer tussle
2018-11-06
Pfizer’s Talzenna approved for breast cancer treatment
2018-10-25
Roche’s breast cancer drug, Kadcyla succeeds phase III trial
2018-10-22
Innovent reports clinical trial results of its anti-PD-1 monoclonal antibody
2018-09-26
Watching Biosimilar Entrants Alongside Blockbuster Patent Expiry Countdown
2018-09-25
AJOVY™, Teva’s new migraine drug gets USFDA approval
2018-09-21
Singapore HSA approves phase I/II clinical trial for precision T-cell receptor immunotherapy
2018-09-14
US FDA Allows Phase II Clinical Trials for China’s anti-HIV Two-Drug Combo Therapy
2018-09-07
Emicizumab promises weekly/biweekly prophylaxis in hemophilia-A patients
2018-09-04
CFDA processes priority review of BGI’s BRCA1/2 gene testing kit
2018-07-11
FDA Released Draft Guidance for Pregnant Women in Clinical Trials
2018-04-19
1 52 53 54
LATEST
Gut Microbiome Composition Predicts Long-term Cardiometabolic Health Outcomes in Diverse Urban Populations
2026-03-12
NVIDIA Ahead of GTC 2026: Markets Focus on Data Center Strength, PC Expansion, and the Next Technical Breakout
2026-03-12
Global and APAC Biopharma Watch: Capital Raising, Clinical Expansion, and Industry Moves in Focus
2026-03-12
Dividend Exchange Rate for Q3 2025 Announced by DEC on March 12, 2026
2026-03-12
NewHydrogen Files International Patent Application for ThermoLoop Technology to Enhance Hydrogen Production Efficiency
2026-03-12
BioGene Therapeutics Inc. Appoints Raj S. Pruthi as Director
2026-03-12
Arista Networks Introduces Liquid-Cooled XPO Optics for Energy-Efficient Data Centers
2026-03-12
Scroll to Top